Commercial insight into the pharma and biotech sector.

World Preview 2014 

The second edition of EvaluatePharma's World Preview brings together many of our analyses to provide a top level insight into the expected performance of the industry between now and 2014. The report highlights the trends in prescription drugs sales, patent risk, R&D spend, global brand sales and therapeutic performance. 

Download World Preview 2014

Key findings include:

  • Worldwide prescription drug sales total $707bn in 2014 with 2.9% (CAGR) over 2009 – 2014
  • Global prescription drug sales flat in 2009
  • Over $182bn of sales at risk from patent expirations in 2011-14
  • Pfizer Maintains Top Spot in 2014 via Wyeth Acquisition
  • Biotech products set to overtake small molecule within Top 100 Drugs from 2014
  • Global pharmaceutical R&D spend to grow by 2.6% (CAGR) to $144bn by 2014
  • Vaccines set to record highest growth of major therapy categories to 2014
  • Sales potential of 2008 new drugs (NMEs) down 14% vs. 2007 cohort of NMEs

3 STEPS TO DOWNLOAD REPORT:

 

1. Click link - World Preview 2014

2. Register your details - or login if Subscriber or Registered User

3. Activate your account to download report - we will send you an email with a download link

Contact Us if you experience any problems.